345 related articles for article (PubMed ID: 35481910)
1. Molecular pathogenesis and emerging targets of gastric adenocarcinoma.
Ivey A; Pratt H; Boone BA
J Surg Oncol; 2022 Jun; 125(7):1079-1095. PubMed ID: 35481910
[TBL] [Abstract][Full Text] [Related]
2. Updates on Management of Gastric Cancer.
Johnston FM; Beckman M
Curr Oncol Rep; 2019 Jun; 21(8):67. PubMed ID: 31236716
[TBL] [Abstract][Full Text] [Related]
3. Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma.
Tan P; Yeoh KG
Gastroenterology; 2015 Oct; 149(5):1153-1162.e3. PubMed ID: 26073375
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer.
Wu Y; Grabsch H; Ivanova T; Tan IB; Murray J; Ooi CH; Wright AI; West NP; Hutchins GG; Wu J; Lee M; Lee J; Koo JH; Yeoh KG; van Grieken N; Ylstra B; Rha SY; Ajani JA; Cheong JH; Noh SH; Lim KH; Boussioutas A; Lee JS; Tan P
Gut; 2013 Aug; 62(8):1100-11. PubMed ID: 22735568
[TBL] [Abstract][Full Text] [Related]
5. A review of the genomics of gastric cancer.
Hamilton JP; Meltzer SJ
Clin Gastroenterol Hepatol; 2006 Apr; 4(4):416-25. PubMed ID: 16616344
[TBL] [Abstract][Full Text] [Related]
6. Genetics of Gastric Cancer.
Strand MS; Lockhart AC; Fields RC
Surg Clin North Am; 2017 Apr; 97(2):345-370. PubMed ID: 28325191
[TBL] [Abstract][Full Text] [Related]
7. Genomic pathobiology of gastric carcinoma.
Katoh H; Ishikawa S
Pathol Int; 2017 Feb; 67(2):63-71. PubMed ID: 28004449
[TBL] [Abstract][Full Text] [Related]
8. New therapeutic options opened by the molecular classification of gastric cancer.
Chivu-Economescu M; Matei L; Necula LG; Dragu DL; Bleotu C; Diaconu CC
World J Gastroenterol; 2018 May; 24(18):1942-1961. PubMed ID: 29760539
[TBL] [Abstract][Full Text] [Related]
9. Mapping the genomic diaspora of gastric cancer.
Yeoh KG; Tan P
Nat Rev Cancer; 2022 Feb; 22(2):71-84. PubMed ID: 34702982
[TBL] [Abstract][Full Text] [Related]
10. Current treatment and recent progress in gastric cancer.
Joshi SS; Badgwell BD
CA Cancer J Clin; 2021 May; 71(3):264-279. PubMed ID: 33592120
[TBL] [Abstract][Full Text] [Related]
11. [HER2 testing in gastric cancer : Results of a meeting of German experts].
Baretton G; Dietel M; Gaiser T; Kirchner T; Kreipe HH; Quaas A; Röcken C; Rüschoff J; Tannapfel A; Lordick F; Al-Batran S; Hofheinz R; Lorenzen S; Moehler M; Thuss-Patience P
Pathologe; 2016 Jul; 37(4):361-6. PubMed ID: 27376648
[TBL] [Abstract][Full Text] [Related]
12. Fluctuations of epigenetic regulations in human gastric Adenocarcinoma: How does it affect?
Samadani AA; Noroollahi SE; Mansour-Ghanaei F; Rashidy-Pour A; Joukar F; Bandegi AR
Biomed Pharmacother; 2019 Jan; 109():144-156. PubMed ID: 30396071
[TBL] [Abstract][Full Text] [Related]
13. Integrated miRNA profiling and bioinformatics analyses reveal potential causative miRNAs in gastric adenocarcinoma.
Zhang X; Peng Y; Jin Z; Huang W; Cheng Y; Liu Y; Feng X; Yang M; Huang Y; Zhao Z; Wang L; Wei Y; Fan X; Zheng D; Meltzer SJ
Oncotarget; 2015 Oct; 6(32):32878-89. PubMed ID: 26460735
[TBL] [Abstract][Full Text] [Related]
14. Gastric Adenocarcinoma: An Update on Genomics, Immune System Modulations, and Targeted Therapy.
Lee J; Bass AJ; Ajani JA
Am Soc Clin Oncol Educ Book; 2016; 35():104-11. PubMed ID: 27249691
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of Gastric Cancer.
Figueiredo C; Costa S; Karameris A; Machado JC
Helicobacter; 2015 Sep; 20 Suppl 1():30-5. PubMed ID: 26372822
[TBL] [Abstract][Full Text] [Related]
16. MSLN (Mesothelin), ANTXR1 (TEM8), and MUC3A are the potent antigenic targets for CAR T cell therapy of gastric adenocarcinoma.
Sotoudeh M; Shirvani SI; Merat S; Ahmadbeigi N; Naderi M
J Cell Biochem; 2019 Apr; 120(4):5010-5017. PubMed ID: 30260046
[TBL] [Abstract][Full Text] [Related]
17. Translating gastric cancer genomics into targeted therapies.
Ang YL; Yong WP; Tan P
Crit Rev Oncol Hematol; 2016 Apr; 100():141-6. PubMed ID: 26947813
[TBL] [Abstract][Full Text] [Related]
18. How Can Gastric Cancer Molecular Profiling Guide Future Therapies?
Corso S; Giordano S
Trends Mol Med; 2016 Jul; 22(7):534-544. PubMed ID: 27260398
[TBL] [Abstract][Full Text] [Related]
19. Review of Survival, Safety, and Clinical Outcomes in HER2+ Metastatic Gastric Cancer Following the Administration of Trastuzumab.
Hackshaw MD; Bui CL; Ladner A; Tu N; Islam Z; Ritchey ME; Salas M
Cancer Treat Res Commun; 2020; 24():100189. PubMed ID: 32673845
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal and molecular pathway alterations in the neuroendocrine carcinoma and adenocarcinoma components of gastric mixed neuroendocrine-nonneuroendocrine neoplasm.
Sun L; Zhang J; Wang C; Zhao S; Shao B; Guo Y; Liu Y; Sun Y
Mod Pathol; 2020 Dec; 33(12):2602-2613. PubMed ID: 32461621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
